Phase I pharmacokinetic and safety trial of intravenous gallium citrate in cystic fibrosis patients

Trial Profile

Phase I pharmacokinetic and safety trial of intravenous gallium citrate in cystic fibrosis patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 May 2013

At a glance

  • Drugs Gallium citrate (Primary)
  • Indications Cystic fibrosis-associated respiratory tract infections; Gram-negative infections; Gram-positive infections; Pseudomonal infections
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 28 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top